{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:59:55Z","timestamp":1793289595010,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Henan Provincial Medical Science and Technology Research Project","award":["LLRGJ20220191"],"award-info":[{"award-number":["LLRGJ20220191"]}]},{"name":"Henan Provincial Science and Technology Project","award":["232102311080"],"award-info":[{"award-number":["232102311080"]}]},{"DOI":"10.13039\/501100013066","name":"Key Scientific Research Project of Colleges and Universities in Henan Province","doi-asserted-by":"publisher","award":["23A320033"],"award-info":[{"award-number":["23A320033"]}],"id":[{"id":"10.13039\/501100013066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan Province International Science and Technology Cooperation Project","award":["232102521031"],"award-info":[{"award-number":["232102521031"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82141127"],"award-info":[{"award-number":["82141127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-C&T-B-057"],"award-info":[{"award-number":["2021-I2M-C&T-B-057"]}]},{"name":"National Key Research and Development Program of China","award":["2023YFC3403800"],"award-info":[{"award-number":["2023YFC3403800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-024-01933-5","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T13:44:51Z","timestamp":1734097491000},"page":"258-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["How different body compositions affect the prognosis of HCC undergoing immunotherapy: the paradoxical phenomenon of BMI"],"prefix":"10.1007","volume":"130","author":[{"given":"Jingzhong","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"1933_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A et al (2021) Hepatocellular carcinoma. Nat Rev Dis Primers 7:6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3","journal-title":"Nat Rev Dis Primers"},{"key":"1933_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A (2022) Hepatocellular carcinoma. Lancet 400:1345\u20131362. https:\/\/doi.org\/10.1016\/S0140-6736(22)01200-4","journal-title":"Lancet"},{"key":"1933_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, Castet F, Heikenwalder M et al (2022) Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol 19:151\u2013172. https:\/\/doi.org\/10.1038\/s41571-021-00573-2","journal-title":"Nat Rev Clin Oncol"},{"key":"1933_CR4","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","volume":"389","author":"AB El-Khoueiry","year":"2017","unstructured":"El-Khoueiry AB, Sangro B, Yau T et al (2017) Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial. Lancet 389:2492\u20132502. https:\/\/doi.org\/10.1016\/S0140-6736(17)31046-2","journal-title":"Lancet"},{"key":"1933_CR5","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M et al (2020) Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med 382:1894\u20131905. https:\/\/doi.org\/10.1056\/NEJMoa1915745","journal-title":"N Engl J Med"},{"key":"1933_CR6","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1200\/JCO.20.00808","volume":"38","author":"RS Finn","year":"2020","unstructured":"Finn RS, Ikeda M, Zhu AX et al (2020) Phase Ib study of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma. J Clin Oncol 38:2960\u20132970. https:\/\/doi.org\/10.1200\/JCO.20.00808","journal-title":"J Clin Oncol"},{"key":"1933_CR7","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625\u20131638. https:\/\/doi.org\/10.1056\/NEJMoa021423","journal-title":"N Engl J Med"},{"key":"1933_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jcsm.12279","volume":"9","author":"R Mayr","year":"2018","unstructured":"Mayr R, Gierth M, Zeman F et al (2018) Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer. J Cachexia Sarcopenia Muscle 9:505\u2013513. https:\/\/doi.org\/10.1002\/jcsm.12279","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1933_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jcsm.12357","volume":"10","author":"RD Dolan","year":"2019","unstructured":"Dolan RD, Almasaudi AS, Dieu LB, Horgan PG, McSorley ST, McMillan DC (2019) The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer. J Cachexia Sarcopenia Muscle 10:111\u2013122. https:\/\/doi.org\/10.1002\/jcsm.12357","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1933_CR10","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcsm.12956","volume":"13","author":"JH Lee","year":"2022","unstructured":"Lee JH, Yoon YC, Kim HS et al (2022) Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma. J Cachexia Sarcopenia Muscle 13:1076\u20131086. https:\/\/doi.org\/10.1002\/jcsm.12956","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1933_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","volume":"63","author":"N Fujiwara","year":"2015","unstructured":"Fujiwara N, Nakagawa H, Kudo Y et al (2015) Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63:131\u2013140. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.031","journal-title":"J Hepatol"},{"key":"1933_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.1241244","volume":"341","author":"RS Ahima","year":"2013","unstructured":"Ahima RS, Lazar MA (2013) Physiology. The health risk of obesity\u2013better metrics imperative. Science 341:856\u2013858. https:\/\/doi.org\/10.1126\/science.1241244","journal-title":"Science"},{"key":"1933_CR13","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/jcsm.12755","volume":"12","author":"Y Takenaka","year":"2021","unstructured":"Takenaka Y, Oya R, Takemoto N, Inohara H (2021) Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis. J Cachexia Sarcopenia Muscle 12:1122\u20131135. https:\/\/doi.org\/10.1002\/jcsm.12755","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1933_CR14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/jitc-2020-000821","volume":"8","author":"AC Young","year":"2020","unstructured":"Young AC, Quach HT, Song H et al (2020) Impact of body composition on outcomes from anti-PD1 +\/- anti-CTLA-4 treatment in melanoma. J Immunother Cancer 8:821. https:\/\/doi.org\/10.1136\/jitc-2020-000821","journal-title":"J Immunother Cancer"},{"key":"1933_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00330-022-08980-4","volume":"33","author":"BB Chen","year":"2023","unstructured":"Chen BB, Liang PC, Shih TT et al (2023) Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma. Eur Radiol 33:512\u2013522. https:\/\/doi.org\/10.1007\/s00330-022-08980-4","journal-title":"Eur Radiol"},{"key":"1933_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/COC.0000000000000787","volume":"44","author":"M Akce","year":"2021","unstructured":"Akce M, Liu Y, Zakka K et al (2021) Impact of Sarcopenia, BMI, and inflammatory biomarkers on survival in advanced hepatocellular carcinoma treated with anti-PD-1 antibody. Am J Clin Oncol 44:74\u201381. https:\/\/doi.org\/10.1097\/COC.0000000000000787","journal-title":"Am J Clin Oncol"},{"key":"1933_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358\u2013380. https:\/\/doi.org\/10.1002\/hep.29086","journal-title":"Hepatology"},{"key":"1933_CR18","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1097\/MEG.0000000000000661","volume":"28","author":"A Hiraoka","year":"2016","unstructured":"Hiraoka A, Michitaka K, Ueki H et al (2016) Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease. Eur J Gastroenterol Hepatol 28:940\u2013947. https:\/\/doi.org\/10.1097\/MEG.0000000000000661","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1933_CR19","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00262-020-02794-3","volume":"70","author":"N Kim","year":"2021","unstructured":"Kim N, Yu JI, Park HC et al (2021) Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab. Cancer Immunol Immunother 70:1593\u20131603. https:\/\/doi.org\/10.1007\/s00262-020-02794-3","journal-title":"Cancer Immunol Immunother"},{"key":"1933_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/cancers14143551","volume":"14","author":"H Matsumoto","year":"2022","unstructured":"Matsumoto H, Tsuchiya K, Nakanishi H et al (2022) Clinical usefulness of monitoring muscle volume during atezolizumab plus bevacizumab therapy in patients with unresectable hepatocellular carcinoma. Cancers (Basel) 14:551. https:\/\/doi.org\/10.3390\/cancers14143551","journal-title":"Cancers (Basel)"},{"key":"1933_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196235","volume":"13","author":"C Stretch","year":"2018","unstructured":"Stretch C, Aubin JM, Mickiewicz B et al (2018) Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas. PLoS ONE 13:e0196235. https:\/\/doi.org\/10.1371\/journal.pone.0196235","journal-title":"PLoS ONE"},{"key":"1933_CR22","doi-asserted-by":"publisher","first-page":"33658","DOI":"10.18632\/oncotarget.16866","volume":"8","author":"GR Williams","year":"2017","unstructured":"Williams GR, Deal AM, Muss HB et al (2017) Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia. Oncotarget 8:33658\u201333665. https:\/\/doi.org\/10.18632\/oncotarget.16866","journal-title":"Oncotarget"},{"key":"1933_CR23","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/jcsm.12538","volume":"11","author":"MP Chu","year":"2020","unstructured":"Chu MP, Li Y, Ghosh S et al (2020) Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma. J Cachexia Sarcopenia Muscle 11:748\u2013755. https:\/\/doi.org\/10.1002\/jcsm.12538","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1933_CR24","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3389\/fimmu.2020.00868","volume":"11","author":"TA Waldmann","year":"2020","unstructured":"Waldmann TA, Dubois S, Miljkovic MD, Conlon KC (2020) IL-15 in the combination immunotherapy of cancer. Front Immunol 11:868. https:\/\/doi.org\/10.3389\/fimmu.2020.00868","journal-title":"Front Immunol"},{"key":"1933_CR25","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1158\/1078-0432.CCR-10-1966","volume":"16","author":"P Yu","year":"2010","unstructured":"Yu P, Steel JC, Zhang M, Morris JC, Waldmann TA (2010) Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model. Clin Cancer Res 16:6019\u20136028. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1966","journal-title":"Clin Cancer Res"},{"key":"1933_CR26","doi-asserted-by":"publisher","first-page":"175628482211424","DOI":"10.1177\/17562848221142417","volume":"15","author":"Y Guo","year":"2022","unstructured":"Guo Y, Ren Y, Wu F, Dong X, Zheng C (2022) Prognostic impact of sarcopenia in patients with hepatocellular carcinoma treated with PD-1 inhibitor. Therap Adv Gastroenterol 15:17562848221142416. https:\/\/doi.org\/10.1177\/17562848221142417","journal-title":"Therap Adv Gastroenterol"},{"key":"1933_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/cancers13246355","volume":"13","author":"M Tenuta","year":"2021","unstructured":"Tenuta M, Gelibter A, Pandozzi C et al (2021) Impact of sarcopenia and inflammation on patients with advanced non-small cell lung cancer (NCSCL) treated with immune checkpoint inhibitors (ICIs): a prospective Study. Cancers (Basel) 13:355. https:\/\/doi.org\/10.3390\/cancers13246355","journal-title":"Cancers (Basel)"},{"key":"1933_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/jitc-2022-005226","volume":"10","author":"JH Lee","year":"2022","unstructured":"Lee JH, Hyung S, Lee J, Choi SH (2022) Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study. J Immunother Cancer 10:226. https:\/\/doi.org\/10.1136\/jitc-2022-005226","journal-title":"J Immunother Cancer"},{"key":"1933_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1470-2045(19)30797-1","volume":"21","author":"A Sanchez","year":"2020","unstructured":"Sanchez A, Furberg H, Kuo F et al (2020) Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study. Lancet Oncol 21:283\u2013293. https:\/\/doi.org\/10.1016\/S1470-2045(19)30797-1","journal-title":"Lancet Oncol"},{"key":"1933_CR30","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3945\/ajcn.113.071399","volume":"99","author":"MC Gonzalez","year":"2014","unstructured":"Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB (2014) Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr 99:999\u20131005. https:\/\/doi.org\/10.3945\/ajcn.113.071399","journal-title":"Am J Clin Nutr"},{"key":"1933_CR31","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2147\/CIA.S67872","volume":"10","author":"S Perna","year":"2015","unstructured":"Perna S, Guido D, Grassi M, Rondanelli M (2015) Association between muscle mass and adipo-metabolic profile: a cross-sectional study in older subjects. Clin Interv Aging 10:499\u2013504. https:\/\/doi.org\/10.2147\/CIA.S67872","journal-title":"Clin Interv Aging"},{"key":"1933_CR32","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.2147\/CMAR.S167417","volume":"10","author":"T Kobayashi","year":"2018","unstructured":"Kobayashi T, Kawai H, Nakano O et al (2018) Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy. Cancer Manag Res 10:2231\u20132239. https:\/\/doi.org\/10.2147\/CMAR.S167417","journal-title":"Cancer Manag Res"},{"key":"1933_CR33","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3390\/cancers15041289","volume":"15","author":"T Hatanaka","year":"2023","unstructured":"Hatanaka T, Yata Y, Saito N et al (2023) Relationship between being overweight and clinical outcomes of ablation therapy for hepatocellular carcinoma under ultrasound guidance: a retrospective analysis. Cancers (Basel) 15:1289. https:\/\/doi.org\/10.3390\/cancers15041289","journal-title":"Cancers (Basel)"},{"key":"1933_CR34","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/ijc.25861","volume":"129","author":"T Arano","year":"2011","unstructured":"Arano T, Nakagawa H, Tateishi R et al (2011) Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. Int J Cancer 129:2226\u20132235. https:\/\/doi.org\/10.1002\/ijc.25861","journal-title":"Int J Cancer"},{"key":"1933_CR35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12032-013-0507-x","volume":"30","author":"T Kerenidi","year":"2013","unstructured":"Kerenidi T, Lada M, Tsaroucha A, Georgoulias P, Mystridou P, Gourgoulianis KI (2013) Clinical significance of serum adipokines levels in lung cancer. Med Oncol 30:507. https:\/\/doi.org\/10.1007\/s12032-013-0507-x","journal-title":"Med Oncol"},{"key":"1933_CR36","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/hep.32049","volume":"74","author":"JC Lai","year":"2021","unstructured":"Lai JC, Tandon P, Bernal W et al (2021) Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American association for the study of liver diseases. Hepatology 74:1611\u20131644. https:\/\/doi.org\/10.1002\/hep.32049","journal-title":"Hepatology"},{"key":"1933_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40644-019-0270-0","volume":"19","author":"H Su","year":"2019","unstructured":"Su H, Ruan J, Chen T, Lin E, Shi L (2019) CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis. Cancer Imaging 19:82. https:\/\/doi.org\/10.1186\/s40644-019-0270-0","journal-title":"Cancer Imaging"},{"key":"1933_CR38","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jhep.2021.07.004","volume":"75","author":"J Bruix","year":"2021","unstructured":"Bruix J, Chan SL, Galle PR, Rimassa L, Sangro B (2021) Systemic treatment of hepatocellular carcinoma: an EASL position paper. J Hepatol 75:960\u2013974. https:\/\/doi.org\/10.1016\/j.jhep.2021.07.004","journal-title":"J Hepatol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01933-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-024-01933-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01933-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T10:52:13Z","timestamp":1740739933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-024-01933-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["1933"],"URL":"https:\/\/doi.org\/10.1007\/s11547-024-01933-5","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"16 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have completed the ICMJE uniform disclosure form and have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was conducted by the Declaration of Helsinki (as revised in 2013) and its amendments, and was approved by the ethical committee of the Henan Cancer Hospital (No. 2023-KY-0075002). Written informed consent for treatment was obtained from all patients. The requirement for written informed consent for participating this study was waived, owing to its retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}